Universal Ibogaine Inc.
IBO.VTSXVHealthcare
$0.01
$-0.01(-50.00%)
Market Cap$1564293
P/E Ratio—
52W High$0.045
52W Low$0.005
Universal Ibogaine Inc. (IBO.V) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · IBO.V · as of 2026-06-09
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2022-07 | 2021-07 | 2020-03 | 2019-03 | 2018-03 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $1.07M | $0.00M | $0.00M | $0.00M | $0.00M |
| Cost of Revenue | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Gross Profit | $1.07M | $0.00M | $0.00M | $0.00M | $0.00M |
| Gross Margin %(computed) | 100.00% | — | — | — | — |
| Operating Expenses | |||||
| R&D Expenses | $0.41M | $0.06M | $0.00M | $0.00M | $0.00M |
| G&A Expenses | $4.57M | $3.53M | $0.06M | $0.07M | $0.18M |
| Total Operating Expenses | $5.82M | $3.86M | $0.06M | $0.07M | $0.18M |
| Operating Income | $0.50M | ($3.83M) | $0.00M | ($0.03M) | $0.06M |
| Operating Margin %(computed) | 46.43% | — | — | — | — |
| Interest Income | $0.00M | $0.03M | $0.00M | $0.01M | $0.01M |
| Interest Expense | $0.07M | $0.02M | $0.00M | $0.00M | $0.00M |
| Income Before Tax | ($10.50M) | ($3.87M) | ($0.12M) | ($0.10M) | ($0.41M) |
| Income Tax Expense | ($0.06M) | $0.02M | $0.06M | $0.00M | $0.00M |
| Net Income | ($10.50M) | ($3.87M) | ($0.12M) | ($0.10M) | ($0.41M) |
| Net Margin %(computed) | -980.22% | — | — | — | — |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-0.06 | $-0.03 | $-0.01 | $-0.01 | $-0.04 |
| Wtd Avg Shares | 185.64M | 125.19M | 11.83M | 9.81M | 10.21M |
| EBITDA | ($4.61M) | ($3.76M) | $0.00M | ($0.03M) | $0.06M |
| EBITDA Margin %(computed) | -430.27% | — | — | — | — |
Data source: Financial Modeling Prep · Last updated: 2026-06-09 · CAD · M
Explore more Universal Ibogaine Inc. data
About Universal Ibogaine Inc. (IBO.V) Income Statement
Universal Ibogaine Inc. (IBO.V) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2022, IBO.V reported revenue of $0.00B, gross profit of $0.00B (gross margin 100.00%), and net income of ($0.01B) — a net profit margin of -980.22%.
Frequently asked questions
IBO.V · 4 questionsUniversal Ibogaine Inc. (IBO.V) reported revenue of $0.00B for 2022, up —% year-over-year.
IBO.V revenueIBO.V salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09